Prot #REALM-1: Randomized, Double-blind, Vehicle-Controlled, Multicenter, Parallel-Group, Phase 2a Study to Assess the Safety and Efficacy of PR022 Topical Gel in Adults with Mild-to-Moderate Atopic Dermatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date3/31/18 → 3/31/21

Funding

  • Symbio, LLC (Prot #REALM-1 // Prot #REALM-1)
  • Realm Therapeutics, Inc. (Prot #REALM-1 // Prot #REALM-1)